Bloomsbury Bioseed Fund is the famous VC, which was founded in 1999. The leading representative office of defined VC is situated in the London. The venture was found in Europe in United Kingdom.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Information Technology, Innovation Management. Among the most popular portfolio startups of the fund, we may highlight Endomag, Canbex Therapeutics.
The top amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2011. Deals in the range of 1 - 5 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, UCLB, Sussex Place Ventures. In the next rounds fund is usually obtained by New Wave Ventures, Wellcome Trust, UCLB.
Fund Name | Location |
Bleu Capital | New York, New York, United States |
BPI Capital Corporation | Makati, Manila, Philippines |
China Literature | Beijing, Beijing, China |
DNB | Norway, Oslo |
Ewert Leaf Labs | Australia, South Melbourne, Victoria |
HB Realty Investments, Inc. | - |
Huijun Venture Capital | China, Shanghai |
Indigo 7 Ventures | - |
Investitions- und Strukturbank Rheinland-Pfalz | Germany, Mainz, Rheinland-Pfalz |
Ionis Pharmaceuticals | California, Carlsbad, United States |
Proto Accelerator | Lansing, Michigan, United States |
RBC | Canada, Ontario, Toronto |
Ruishuo Capital | China, Shanghai |
Silicon Solution Ventures | - |
Silverblue | - |
Skeleton Technologies | Estonia, Harjumaa, Tallinn |
Startup Grind | California, San Francisco, United States |
Taihe Entertainment Group | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Endomag | $1M | 05 Aug 2011 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Endomag | $1M | 05 Aug 2011 | England |